Integrated Biosciences ^Company

Integrated Biosciences is a cutting-edge organization that focuses on developing next-generation therapeutics for age-related diseases. With breakthrough publications in prestigious scientific journals like Nature and Science, the organization has demonstrated the first AI-driven discovery of anti-aging drug candidates and a novel structural class of antibiotics. Using a combination of light-based biology control and machine learning, Integrated Biosciences aims to design novel therapeutics that target the transcriptome and rejuvenate cells. Their proprietary synthetic biology technology allows them to virtually activate cellular stress responses, discover drugs targeting stressed cells, and rapidly identify drug targets, with the goal of mediating healthy aging and improving overall health outcomes.